 |
answer text |
<p>European Union Framework Programme funding for United Kingdom-based projects, including
those on cancer research, will not necessarily be linked to the UK’s involvement in
the European Research Area.</p><p> </p><p>If we leave with the Withdrawal Agreement,
UK participants will still be eligible for funding from Horizon 2020, including for
cancer research projects. As a responsible Government, we are continuing to prepare
for a ‘no deal’ scenario. In a ‘no deal’ scenario, the Government has committed to
fund all successful UK bids to Horizon 2020 submitted before the end of 2020 and for
the lifetime of projects. This guarantee will enable UK researchers and businesses
to continue to access funding required to participate in Horizon 2020 and will support
ongoing world-leading collaboration, including in cancer research.</p><p> </p><p>Looking
beyond Horizon 2020, in any scenario we want to continue to back the UK research and
innovation community by supporting the provision of opportunities for world-class
collaborative research. We are continuing to seek a relationship with the European
Union on science and innovation including the option of future association to excellence-based
EU research and innovation funding programmes.</p><p> </p><p>National Institute for
Health Research cancer research expenditure has risen from £101 million in 2010/11
to £136 million in 2017/18. This constitutes the largest investment in a disease area.
A large proportion of this funding comprises support for the delivery of Cancer Research
UK-funded research in the National Health Service.</p>
|
|
